Bachem Holding AG Class B (CH:BANB)
:BANB
Want to see CH:BANB full AI Analyst Report?
BANB Stock Chart & Stats
CHF70.15
CHF0.05(0.09%)
At close: 4:00 PM EST
CHF70.15
CHF0.05(0.09%)
Day’s Range― - ―
52-Week RangeCHF46.16 - CHF76.00
Previous CloseN/A
Volume38.68K
Average Volume (3M)109.83K
Market Cap
CHF5.47B
Enterprise ValueCHF5.22B
Total Cash (Recent Filing)CHF30.99M
Total Debt (Recent Filing)CHF57.39M
Price to Earnings (P/E)30.2
Beta0.78
Next Earnings
Jul 21, 2026EPS Estimate
0.73Next Dividend Ex-DateN/A
Dividend Yield1.43%
Share Statistics
EPS (TTM)1.32
Shares Outstanding75,000,000
10 Day Avg. Volume97,857
30 Day Avg. Volume109,830
Financial Highlights & Ratios
PEG Ratio1.27
Price to Book (P/B)3.08
Price to Sales (P/S)6.46
P/FCF Ratio-93.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF84.20Price Target Upside20.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)2.39
Revenue Forecast (FY)CHF949.88M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage and a growing equity base give Bachem durable financial flexibility. Low debt reduces refinancing and interest-rate risk, supports capital allocation choices, and underpins resilience through industry cycles, enabling steady investment in capacity or R&D without pressure from creditors.
Steady Revenue And Strong MarginsMulti-year top-line growth plus a healthy ~21% net margin indicate durable operating strength from higher-value peptide work. Consistent profitability suggests pricing power or operating efficiencies in peptide API manufacturing that support sustainable earnings generation over the medium term.
Recurring Commercial Supply ModelLong-term commercial supply contracts tie Bachem revenues to lifecycle sales of customers' marketed drugs, creating recurring demand and visibility. Combined with development-to-commercial project flows, this model supports durable revenue conversion as projects scale from R&D into sustained commercial supply.
Bears Say
Persistent Negative Free Cash FlowSustained negative free cash flow signals that capital expenditures or working-capital demands consistently absorb cash. Over months to years this can constrain the company's ability to self-fund expansion, raise dividends, or buffer downturns without tapping external financing despite the conservative balance sheet.
Inconsistent Cash ConversionUneven conversion of net income into operating cash undermines earnings quality. For a contract manufacturer, variable working capital or timing of milestone billings can create volatility in available cash, complicating reinvestment planning and increasing reliance on financial management to smooth funding needs.
Margin Compression & Growth ModerationA gradual erosion of margins and decelerating revenue growth versus the earlier step-up indicate potential pricing, mix, or cost pressures. Over the medium term, this trend could limit margin expansion potential and requires monitoring of pricing power and productivity to sustain long-term profitability.
Bachem Holding AG News
BANB FAQ
What was Bachem Holding AG Class B’s price range in the past 12 months?
Bachem Holding AG Class B lowest stock price was CHF46.16 and its highest was CHF76.00 in the past 12 months.
What is Bachem Holding AG Class B’s market cap?
Bachem Holding AG Class B’s market cap is CHF5.47B.
When is Bachem Holding AG Class B’s upcoming earnings report date?
Bachem Holding AG Class B’s upcoming earnings report date is Jul 21, 2026 which is in 91 days.
How were Bachem Holding AG Class B’s earnings last quarter?
Bachem Holding AG Class B released its earnings results on Mar 12, 2026. The company reported CHF1.317 earnings per share for the quarter, beating the consensus estimate of CHF0.88 by CHF0.437.
Is Bachem Holding AG Class B overvalued?
According to Wall Street analysts Bachem Holding AG Class B’s price is currently Undervalued.
Does Bachem Holding AG Class B pay dividends?
Bachem Holding AG Class B pays a Annually dividend of CHF0.85 which represents an annual dividend yield of 1.43%. See more information on Bachem Holding AG Class B dividends here
What is Bachem Holding AG Class B’s EPS estimate?
Bachem Holding AG Class B’s EPS estimate is 0.73.
How many shares outstanding does Bachem Holding AG Class B have?
Bachem Holding AG Class B has 75,000,000 shares outstanding.
What happened to Bachem Holding AG Class B’s price movement after its last earnings report?
Bachem Holding AG Class B reported an EPS of CHF1.317 in its last earnings report, beating expectations of CHF0.88. Following the earnings report the stock price went up 7.734%.
Which hedge fund is a major shareholder of Bachem Holding AG Class B?
Currently, no hedge funds are holding shares in CH:BANB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bachem Holding AG Class B
Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
BANB Stock 12 Month Forecast
Average Price Target
CHF84.20
▲(20.03% Upside)
Technical Analysis
Lonza Group Ltd
―
Siegfried Holding AG
―
Ypsomed Holding AG
―
PolyPeptide Group AG
―
Galenica AG
―
Options Prices
Currently, No data available
---